Back to 
FIL Ltd
FIL Ltd
AXSM
Showing 0 of 9 quarters
Position history for FIL Ltd's holdings in Axsome Therapeutics, Inc.
No. FIL exited its AXSM (Axsome Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 10,176 shares worth $686,000. FIL first reported AXSM in Q3 2019 and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.